Mammoth Energy Services, Inc. (TUSK)

NASDAQ: TUSK · Real-Time Price · USD

2.540

-0.060 (-2.31%)

At close: Aug 1, 2025, 4:00 PM

2.740

+0.200 (7.87%)

After-hours: Aug 1, 2025, 7:38 PM EDT

Revance Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Revance Therapeutics.

Price Target: $0.00 (0.00%)

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Revance Therapeutics.

Recommendation Trends

Rating	Dec '22	Jan '23	Feb '23	Mar '23	Apr '23
Strong Buy	0	0	0	0	1
Buy	0	0	0	0	0
Hold	4	4	4	4	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	4	4	4	4	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Reilly EF Hutton	EF Hutton	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+136.22%	May 25, 2023
Ignacio Bernaldez EF Hutton	EF Hutton	Strong Buy Maintains $7 → $6	Strong Buy	Maintains	$7 → $6	+136.22%	Apr 28, 2023
Ignacio Bernaldez EF Hutton	EF Hutton	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+175.59%	Apr 20, 2023
Tommy Moll Stephens & Co.	Stephens & Co.	Hold Maintains $2 → $1	Hold	Maintains	$2 → $1	-60.63%	Mar 2, 2020
Jason Wangler Imperial Capital	Imperial Capital	Buy → Hold Downgrades $6 → $1.5	Buy → Hold	Downgrades	$6 → $1.5	-40.94%	Nov 11, 2019

More Analyst Ratings

Financial Forecast

Revenue This Year

167.16M

from 187.93M

-11.05%

from 187.93M

Revenue Next Year

214.33M

from 167.16M

28.22%

from 167.16M

EPS This Year

-0.30

from -4.31

EPS Next Year

-0.05

from -0.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	313.08M	228.96M	362.09M	309.49M	187.93M	167.16M	214.33M
Revenue Growth	-49.91%	-26.87%	58.14%	-14.53%	-39.28%	-11.05%	28.22%
EPS	-2.36	-2.18	-0.01	-0.07	-4.31	-0.30	-0.05
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	172.1M	220.6M
Avg	167.2M	214.3M
Low	160.6M	205.9M

Revenue Growth

Revenue Growth	2025	2026
High	-8.4%	32.0%
Avg	-11.1%	28.2%
Low	-14.5%	23.2%

EPS Forecast

EPS	2025	2026
High	-0.30	-0.05
Avg	-0.30	-0.05
Low	-0.28	-0.05

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.